newsfilter
← Latest News
GlobeNewswire·

PharmaTher Holdings Provides Corporate Update

Company funded to meet upcoming milestones over the next 24 months Expected FDA approval for KETARX™ (racemic ketamine) via the ANDA pathway in Q1-2024 and international approvals after that Company advancing